Q1
NEOG — Q1 2026 Financial Report Analysis (Fiscal Q1 2027)
Neogen's revenue rose 6.5% to $222.8M and its operating loss shrank to $1.8M in the quarter to August 31, 2026, as Petrifilm and pathogen-test sales grew; it posted a $11.9M net loss only because last year included a $76.4M divestiture gain, and it raised FY2027 guidance slightly.